Fibroblast growth factor receptor 1 gene amplification in gastric adenocarcinoma

Human Pathology

Volumn 46, Issue 10, 2015, Pages 1488-1495

  Schäfer, Manuel H ^a   Lingohr, Philipp ^a   Sträßer, Anke ^a,b   Lehnen, Nils C ^a   Braun, Martin ^a   Perner, Sven ^a   Höller, Tobias ^a   Kristiansen, Glen ^a   Kalff, Jörg C ^a   Gütgemann, Ines ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b St Elisabeth Hospital   (Germany)

Author keywords

Amplification; FGFR1; Fibroblast growth factor receptor 1; FISH; Fluorescence in situ hybridization; Gastric adenocarcinoma; Gastric cancer

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; STOMACH ADENOCARCINOMA; TISSUE MICROARRAY; ADENOCARCINOMA; GENETICS; HIGH THROUGHPUT SCREENING; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; STOMACH TUMOR; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE AMPLIFICATION; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 84941941913     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2015.06.007     Document Type: Article

References (35)

1. J. Ferlay, I. Soerjomataram, R. Dikshit, and et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 2015 E359 E386
2. J.M. Yeh, C. Hur, D. Schrag, and et al. Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model PLoS Med 10 2013 e1001451
3. T. Yamashita, M. Yoshioka, and N. Itoh Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain Biochem Biophys Res Commun 277 2000 494 498
4. N. Turner, and R. Grose Fibroblast growth factor signalling: from development to cancer Nat Rev Cancer 10 2010 116 129
5. R. Dienstmann, J. Rodon, A. Prat, and et al. Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors Ann Oncol 25 2014 552 563
6. J. Weiss, M.L. Sos, D. Seidel, and et al. Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer Sci Transl Med 2 2010 62ra93
7. K. Freier, C. Schwaenen, C. Sticht, and et al. Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC) Oral Oncol 43 2007 60 66
8. S. Elbauomy Elsheikh, A.R. Green, M.B. Lambros, and et al. FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis Breast Cancer Res 9 2007 R23
9. C. Theillet, J. Adelaide, G. Louason, and et al. FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers Genes Chromosomes Cancer 7 1993 219 226
10. R. Simon, J. Richter, U. Wagner, and et al. High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer Cancer Res 61 2001 4514 4519
11. N.C. Lehnen, A. von Massenhausen, H. Kalthoff, and et al. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma Histopathology 63 2013 157 166
12. M. Koziczak, T. Holbro, and N.E. Hynes Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins Oncogene 23 2004 3501 3508
13. F.R. Lamont, D.C. Tomlinson, P.A. Cooper, and et al. Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo Br J Cancer 104 2011 75 82
14. A. Dutt, A.H. Ramos, P.S. Hammerman, and et al. Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer PLoS One 6 2011 e20351
15. J.H. Jang, K.H. Shin, and J.G. Park Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers Cancer Res 61 2001 3541 3543
16. L. Xie, X. Su, L. Zhang, and et al. FGFR2 gene amplification in gastric cancer predicts sensitivity to the selective FGFR inhibitor AZD4547 Clin Cancer Res 19 2013 2572 2583
17. K. Matsumoto, T. Arao, T. Hamaguchi, and et al. FGFR2 gene amplification and clinicopathological features in gastric cancer Br J Cancer 106 2012 727 732
18. J.T. Ney, H. Zhou, B. Sipos, and et al. Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts Hum Pathol 38 2007 359 364
19. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind International Union Against Cancer (UICC) TNM classification of malignant tumours 2009 Wiley-Blackwell Oxford, UK
20. P. Lauren The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 1965 31 49
21. F.T. Bosman, F. Carneiro, R.H. Hruban, and N.D. Theise WHO classification of tumours of the digestive system 2010 IARC Lyon
22. F. Goke, A. Goke, A. von Massenhausen, and et al. Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer Digestion 88 2013 172 181
23. A.M. Dulak, S.E. Schumacher, J. van Lieshout, and et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis Cancer Res 72 2012 4383 4393
24. Y. Hattori, H. Itoh, S. Uchino, and et al. Immunohistochemical detection of K-sam protein in stomach cancer Clin Cancer Res 2 1996 1373 1381
25. T. Toyokawa, M. Yashiro, and K. Hirakawa Co-expression of keratinocyte growth factor and K-sam is an independent prognostic factor in gastric carcinoma Oncol Rep 21 2009 875 880
26. H. Murase, M. Inokuchi, Y. Takagi, and et al. Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer Mol Clin Oncol 2 2014 509 517
27. E.Y. Shin, B.H. Lee, J.H. Yang, and et al. Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer J Cancer Res Clin Oncol 126 2000 519 528
28. X. Su, P. Zhan, P.R. Gavine, and et al. FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study Br J Cancer 110 2014 967 975
29. F. Wang, W. Meng, B. Wang, and L. Qiao Helicobacter pylori-induced gastric inflammation and gastric cancer Cancer Lett 345 2014 196 202
30. V. Guagnano, A. Kauffmann, S. Wohrle, and et al. FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor Cancer Discov 2 2012 1118 1133
31. M. Takeda, T. Arao, H. Yokote, and et al. AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor Clin Cancer Res 13 2007 3051 3057
32. J.M. Gozgit, M.J. Wong, L. Moran, and et al. Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models Mol Cancer Ther 11 2012 690 699
33. M. Katoh, and H. Nakagama FGF receptors: cancer biology and therapeutics Med Res Rev 34 2014 280 300
34. K. Bauer, M. Schroeder, F. Porzsolt, and D. Henne-Bruns Comparison of international guidelines on the accompanying therapy for advanced gastric cancer: reasons for the differences J Gastric Cancer 15 2015 10 18
35. A. Morishita, J. Gong, and T. Masaki Targeting receptor tyrosine kinases in gastric cancer World J Gastroenterol 20 2014 4536 4545